Quotes 5-day view Delayed Nasdaq
1 568 161
1 538 573
Estimated financial data (e) (USD)
Net income 2021
Net cash position 2021
P/E ratio 2021
Net income 2022
Net cash position 2022
P/E ratio 2022
EV / Sales 2021
EV / Sales 2022
Nbr of Employees
Mersana Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing antibody drug conjugates (ADCs). The CompanyÔÇÖs platforms include Dolaflexin and Dolasynthen. Its product candidates include upifitamab rilsodotin (UpRi, XMT-1536) and XMT-1592. The CompanyÔÇÖs early stage programs include B7-H4-targeted Dolasynthen ADC, XMT-1660, as well as candidates leveraging the...
Ratings of Mersana Therapeutics, Inc.
All news about MERSANA THERAPEUTICS, INC.
09/10 MERSANA THERAPEUTICS : Plummets Following Interim Phase 1 Ovarian Cancer Trial Data
09/10 MERSANA THERAPEUTICS : UpRi Clinical Development Strategy and Interim Data from the Ovaria..
09/10 MERSANA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
09/07 Mersana Therapeutics to Present at Upcoming Investor Conferences
09/01 MERSANA THERAPEUTICS : to Provide Update on the Progress of its UpRi Clinical Development ..
08/30 MERSANA THERAPEUTICS : HC Wainwright Starts Mersana Therapeutics at Buy With $28 Price Tar..
08/18 MERSANA THERAPEUTICS : Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/16 MERSANA THERAPEUTICS : Dr. Misra to succeed Michael Kaufman, Ph.D., Chief Manufacturing Of..
08/16 MERSANA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Disc..
08/16 MERSANA THERAPEUTICS : Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturin..
08/16 Mersana Therapeutics, Inc. Announces Executive Changes
08/06 MERSANA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
08/06 MERSANA THERAPEUTICS' : Q2 Loss Widens, Collaboration Revenue Declines
08/06 MERSANA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Stat..
08/06 MERSANA THERAPEUTICS : Announces Second Quarter 2021 Financial Results and Provides Busine..
News in other languages on MERSANA THERAPEUTICS, INC.
Analyst Recommendations on MERSANA THERAPEUTICS, INC.
Chart MERSANA THERAPEUTICS, INC.
Technical analysis trends MERSANA THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target